Apart from changes in TNF‐α and catalase levels, type 2 diabetes patients showed a trend towards decreased concentration of EGF, and reduced expression of HMOX1 , compensated by an upregulation of HMOX2 .
← all excerpts
Number of circulating pro-angiogenic cells, growth factor and anti-oxidative gene profiles might be altered in type 2 diabetes with and without diabetic foot syndrome.
1
—
—